Stock Research for ENZ

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ENZ Stock Chart & Research Data

The ENZ chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ENZ chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ENZ Due diligence Resources & Stock Charts

The ENZ stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ENZ Detailed Price Forecast - CNN Money CNN View ENZ Detailed Summary - Google Finance
Yahoo View ENZ Detailed Summary - Yahoo! Finance Zacks View ENZ Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ENZ Trends & Analysis - Trade-Ideas Barrons View ENZ Major Holders - Barrons
NASDAQ View ENZ Call Transcripts - NASDAQ Seeking View ENZ Breaking News & Analysis - Seeking Alpha
Spotlight View ENZ Annual Report - CompanySpotlight.com OTC Report View ENZ OTC Short Report - OTCShortReport.com
TradeKing View ENZ Fundamentals - TradeKing Charts View ENZ SEC Filings - Bar Chart
WSJ View Historical Prices for ENZ - The WSJ Morningstar View Performance/Total Return for ENZ - Morningstar
MarketWatch View the Analyst Estimates for ENZ - MarketWatch CNBC View the Earnings History for ENZ - CNBC
StockMarketWatch View the ENZ Earnings - StockMarketWatch MacroAxis View ENZ Buy or Sell Recommendations - MacroAxis
Bullish View the ENZ Bullish Patterns - American Bulls Short Pains View ENZ Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ENZ Stock Mentions - StockTwits PennyStocks View ENZ Stock Mentions - PennyStockTweets
Twitter View ENZ Stock Mentions - Twitter Invest Hub View ENZ Investment Forum News - Investor Hub
Yahoo View ENZ Stock Mentions - Yahoo! Message Board Seeking Alpha View ENZ Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ENZ - SECform4.com Insider Cow View Insider Transactions for ENZ - Insider Cow
CNBC View ENZ Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ENZ - OTC Markets
Yahoo View Insider Transactions for ENZ - Yahoo! Finance NASDAQ View Institutional Holdings for ENZ - NASDAQ


Stock Charts

FinViz View ENZ Stock Insight & Charts - FinViz.com StockCharts View ENZ Investment Charts - StockCharts.com
BarChart View ENZ Stock Overview & Charts - BarChart Trading View View ENZ User Generated Charts - Trading View




Latest Financial News for ENZ


Enzo Biochem: Fiscal 1Q Earnings Snapshot
Posted on Monday December 10, 2018

The New York-based company said it had a loss of 13 cents per share. The life sciences and biotechnology company posted revenue of $21.3 million in the period. In the final minutes of trading on Monday, ...


Enzo Biochem Reports Fiscal 2019 First Quarter Results
Posted on Monday December 10, 2018

Recent Reimbursement Cuts Emphasize Value of Enzo’s Strategy


Enzo Biochem Schedules Teleconference to Discuss First Quarter 2019 Results Tuesday, December 11, 2018 at 8:30 AM E.T.
Posted on Thursday December 06, 2018

Enzo Biochem, Inc. , an integrated diagnostic and therapeutics company, will hold a conference call to discuss fiscal 2019 first quarter results Tuesday, December 11, 2018, at 8:30 AM E.T.


Enzo Biochem Reports Publication of Study on Therapeutic Candidate SK1-I Detailing Promising Results in a Model of Treatment-Resistant Breast Cancer
Posted on Monday December 03, 2018

Enzo Biochem, Inc. (ENZ), an integrated diagnostics and therapeutics company, today reported the publication of a study in the Journal of Lipid Research by researchers at a collaborating institution that shows SK1-I, the company’s proprietary Sphingosine Kinase 1 inhibitor drug candidate, was effective in reversing resistance to the breast cancer drug tamoxifen in a tamoxifen-resistant human breast cancer cell line. As pointed out in the publication, endocrine therapy, such as tamoxifen, is a first line treatment for estrogen receptor-positive breast cancer patients.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.